PharmExec Blog
Follow Us
RSS
Bookstore
Category Archives: healthcare
Helping Patients Lead the Way in the New NHS
Helping patients lead the way in NHS England
Jacky Law investigates how pharma companies can effectively become part of NHS England
NHS England is currently undergoing profound changes to introduce a new culture where clinicians and patients are the new stars, where competition is mandatory, where everything rests on patient outcomes and where collaboration and innovation are [...]
Also posted in Global, Guest Blog, Op-Ed Leave a comment
FT Healthcare Conference: Society as Stakeholder
Speakers at the 2nd annual Financial Times US Healthcare and Life Sciences conference in New York last week discussed the cost of health, and the implications of an increasingly vocal and influential stakeholder group: the local populace.
After opening remarks from Andrew Jack, FT’s prolific pharmaceuticals correspondent, Pfizer CEO Ian Read took the stage at the [...]
Also posted in Europe, Events, Global, Market Access, Orphan Drugs, People, R&D, Regulatory, Strategy, Technology, leadership, pricing Tagged Andrew Jack, big data, cost sharing, David Meeker, drug pricing, Europe, Financial Times, Genzyme, GNS Healthcare, health insurance, Ian Read, MDxHealth, Pfizer, pricing and reimbursement, Sandoz, shared value, Technology, transparency Leave a comment
Five Ways Advanced Social Intelligence Guides Pharma Strategy
by Mark Langsfeld
Within the billions of daily comments from individuals across open social sources lies deep intelligence into markets, brands, patients, caregivers, healthcare providers and competitors. Several leading pharmaceutical companies are already using big data solutions to extract insights from the social realm. Applying these insights across a number of business functions empowers their decision-making [...]
Patent Settlements Become More Risky